CDT Price Action: According to data from Benzinga Pro, Conduit Pharmaceuticals has a 52-week high of $12.89 and a 52-week low of $0.21. Shares closed out Tuesday up 4.63% at 25 cents.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Conduit Pharmaceuticals Inc. announced that it presented a compliance plan to Nasdaq regarding its listing rules, specifically seeking an extension to comply with minimum bid price and market ...

Although price volatility is high ... A scientist in a lab running tests on a variety of biopharmaceuticals. Conduit ...

Collaboration reinforces Conduit’s commitment to leveraging AI and cybernetics to reduce human error, lower costs, and accelerate timelines in drug development Sarborg delivers a prototype AI ...

Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ('Conduit Pharmaceuticals' or 'Conduit' or the 'Company”) announces that, on February 11, 2025, the Company presented its plan of compliance to The Nasdaq ...

NAPLES, Fla. and CAMBRIDGE, United Kingdom, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), is ...